Name: UMIN ID:
Unique ID issued by UMIN | UMIN000033062 |
---|---|
Receipt number | R000037700 |
Scientific Title | Phase II study of DFP-14323 with low dose EGFR-TKI for EGFR mutation positive NSCLC. |
Date of disclosure of the study information | 2018/06/20 |
Last modified on | 2022/06/07 14:02:27 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2018/06/20 12:17:00 | ||
2 | Update | 2018/11/13 13:21:25 | Interventions/Control_1 Interventions/Control_1 Key exclusion criteria Key exclusion criteria |
|
3 | Update | 2018/11/13 13:32:17 | Other related information Other related information |
|
4 | Update | 2019/07/10 13:49:44 | Interventions/Control_1 Interventions/Control_1 |
|
5 | Update | 2019/07/10 14:00:29 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Organization Organization Division name Division name Zip code Address Address TEL Last name of contact person Last name of contact person Zip code Address Organization Organization Address Address Tel Institutions |
|
6 | Update | 2019/07/10 14:16:21 | Date of IRB Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded Other related information Other related information |
|
7 | Update | 2021/04/19 20:59:54 | Recruitment status |
|
8 | Update | 2022/06/07 14:02:27 | Last follow-up date |